PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
Zhao Zhong Chong(Cellular Research (United States)), Kenneth Maiese(Rutgers Cancer Institute of New Jersey)
Cited by 74
Related Papers
The Vitamin Nicotinamide: Translating Nutrition into Clinical Care
|Molecules|2009|234
The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.
|PubMed|2007|229
Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
|Aging|2012|131
Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
|Current Neurovascular Research|2006|82
WISP1 Neuroprotection Requires FoxO3a Post-Translational Modulation with Autoregulatory Control of SIRT1
|Current Neurovascular Research|2012|6